Rapidly progressive parkinsonism in a self‐reported user of Ecstasy and other drugs
- 26 September 2003
- journal article
- case report
- Published by Wiley in Movement Disorders
- Vol. 18 (11) , 1378-1381
- https://doi.org/10.1002/mds.10623
Abstract
A 38‐year‐old man developed parkinsonism that progressed to Hoehn and Yahr stage 5 within 4 years of onset. Response to ropinirole deteriorated, levodopa was not tolerated, and subthalamic nucleus stimulation has provided only partial relief of symptoms. He reported heavy use of Ecstasy through most of his twenties and thirties. His neurological problems may be unrelated to his drug use, but it is also possible they represent an idiosyncratic reaction. © 2003 Movement Disorder SocietyKeywords
This publication has 33 references indexed in Scilit:
- Cognitive Performance of MDMA-Treated Rhesus Monkeys, Sensitivity to Serotonergic ChallengeNeuropsychopharmacology, 2002
- Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?Neuroscience Letters, 2002
- RETRACTED: Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy")Science, 2002
- Parkinsonism after Taking EcstasyNew England Journal of Medicine, 1999
- Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy VolunteersNeuropsychopharmacology, 1998
- Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficitsJournal of Psychopharmacology, 1998
- Neurological sequelae of cyanide intoxication — the patterns of clinical, magnetic resonance imaging, and positron emission tomography findingsAnnals of Neurology, 1995
- Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeysNeurotoxicology and Teratology, 1995
- Neurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findingsMovement Disorders, 1994
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983